SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-23-000335
Filing Date
2023-03-17
Accepted
2023-03-17 16:19:41
Documents
2
Group Members
CARL L. GORDONEREZ CHIMOVITSORBIMED ISRAEL GP LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss1880809_sc13da.htm SC 13D/A 113121
2 JOINT FILING AGREEMENT ss1880809_ex9901.htm EX-99.1 6249
  Complete submission text file 0000947871-23-000335.txt   121102
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 1022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel BioFund GP Limited Partnership (Filed by) CIK: 0001569821 (see all company filings)

IRS No.: 980697985 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90744 | Film No.: 23742862
SIC: 2836 Biological Products, (No Diagnostic Substances)